MedPath

Gallium citrate Ga-67

Generic Name
Gallium citrate Ga-67
Brand Names
Gallium
Drug Type
Small Molecule
Chemical Formula
C6H5GaO7
CAS Number
41183-64-6
Unique Ingredient Identifier
4LJK511Z86
Background

Gallium citrate Ga 67 is the citrate salt of the radioisotope gallium Ga 67. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization. Ga-67 scintigraphy (GS) cannot differentiate between tumor and acute inflammation. [NCI Thesaurus]

Indication

Gallium Citrate Ga 67 Injection may be useful to demonstrate the presence and extent of Hodgkin's disease, lymphoma, and bronchogenic carcinoma. Positive gallium Ga-67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Gallium Citrate Ga 67 Injection may be useful as an aid in detecting some acute inflammatory lesions.

Associated Conditions
Bronchogenic Carcinoma, Hodgkins Disease (HD), Lymphomas NEC, Acute inflammatory lesions
Associated Therapies
-

Ga-68 MAA Distribution in PAE Patients

Early Phase 1
Withdrawn
Conditions
Benign Prostatic Hyperplasia
Interventions
First Posted Date
2020-01-28
Last Posted Date
2021-01-15
Lead Sponsor
University of North Carolina, Chapel Hill
Registration Number
NCT04243824
Locations
🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath